Analysis calculates $725M in economic potential from expanded cancer treatment access

A recent analysis, published in The Lancet Oncology, calculates that increasing access to [¹⁷⁷Lu]PSMA therapy for eligible patients could generate $725 million in economic potential. This impact is projected across nine selected countries between 2023 and 2029.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup